Matches in SemOpenAlex for { <https://semopenalex.org/work/W2435169430> ?p ?o ?g. }
- W2435169430 endingPage "559" @default.
- W2435169430 startingPage "509" @default.
- W2435169430 abstract "Evaluating the use of antithrombotic drugs in artery disease has been a long and difficult process, which is far from complete. The aims of treatment have ranged from the primary prevention of myocardial infarction or stroke, through the restoration of blood flow to ischaemic organs in order to salvage threatened tissue, to the prevention of recurrent vascular occlusion. Drugs studied in depth by clinical trial include the oral anticoagulants, antiplatelet drugs (especially aspirin), and thrombolytic agents. Their results are considered under the headings of coronary artery disease, cerebral ischaemia, and peripheral vascular disease. Aspirin, with or without dipyridamole, prevents progression of unstable angina to myocardial infarction or death, probably reduces long-term mortality after myocardial infarction, and prevents aortocoronary bypass graft occlusion. It decreases the risks of stroke or death in patients with transient cerebral ischaemia, diminishes cardiovascular morbidity after a thrombotic stroke, and may improve the outcome after some kinds of surgery for peripheral vascular disease. The benefits of oral anticoagulant treatment to prevent artery occlusion remain poorly defined. Oral anticoagulants prevent systemic embolism in many groups of high-risk patients, and probably reduce the risk of recurrence after embolism has occurred. Whether their long-term use to prevent reinfarction in patients with a previous myocardial infarct can be justified remains uncertain. They are of little or no proven value in patients with transient cerebral ischaemia or thrombotic stroke. On the other hand, there is increasing support for early thrombolytic treatment after myocardial infarction, especially since two multicentre trials have now shown reduced mortality in patients treated with intracoronary streptokinase within 4-6 hours of infarction and a further large multicentre study also demonstrated reduced mortality in patients treated with early intravenous streptokinase. In addition, the local infusion of streptokinase leads to recanalization in a high proportion of patients with a recent peripheral artery occlusion who are poor candidates for surgery." @default.
- W2435169430 created "2016-06-24" @default.
- W2435169430 creator A5022452046 @default.
- W2435169430 date "1986-05-01" @default.
- W2435169430 modified "2023-09-29" @default.
- W2435169430 title "11 The Use of Antithrombotic Drugs in Artery Disease" @default.
- W2435169430 cites W110994545 @default.
- W2435169430 cites W1213947386 @default.
- W2435169430 cites W1260428 @default.
- W2435169430 cites W1497692885 @default.
- W2435169430 cites W1539849506 @default.
- W2435169430 cites W1570096835 @default.
- W2435169430 cites W1607743415 @default.
- W2435169430 cites W193188632 @default.
- W2435169430 cites W1964324242 @default.
- W2435169430 cites W1966983468 @default.
- W2435169430 cites W1967794997 @default.
- W2435169430 cites W1968278735 @default.
- W2435169430 cites W1970218396 @default.
- W2435169430 cites W1970968315 @default.
- W2435169430 cites W1974595529 @default.
- W2435169430 cites W1974614925 @default.
- W2435169430 cites W1976900430 @default.
- W2435169430 cites W1978257967 @default.
- W2435169430 cites W1978880675 @default.
- W2435169430 cites W1979496157 @default.
- W2435169430 cites W1980122652 @default.
- W2435169430 cites W1980714580 @default.
- W2435169430 cites W1980859840 @default.
- W2435169430 cites W1981878147 @default.
- W2435169430 cites W1983313299 @default.
- W2435169430 cites W1984620961 @default.
- W2435169430 cites W1985720932 @default.
- W2435169430 cites W1987627499 @default.
- W2435169430 cites W1991389233 @default.
- W2435169430 cites W1991480317 @default.
- W2435169430 cites W1993535521 @default.
- W2435169430 cites W1993922642 @default.
- W2435169430 cites W1993999213 @default.
- W2435169430 cites W1994336882 @default.
- W2435169430 cites W1995772643 @default.
- W2435169430 cites W1995789574 @default.
- W2435169430 cites W1996177193 @default.
- W2435169430 cites W1996801902 @default.
- W2435169430 cites W1999060967 @default.
- W2435169430 cites W2001293099 @default.
- W2435169430 cites W200313657 @default.
- W2435169430 cites W2005572664 @default.
- W2435169430 cites W2006755299 @default.
- W2435169430 cites W2008711806 @default.
- W2435169430 cites W2009193823 @default.
- W2435169430 cites W2009560671 @default.
- W2435169430 cites W2009739295 @default.
- W2435169430 cites W2010793394 @default.
- W2435169430 cites W2010814370 @default.
- W2435169430 cites W2011030196 @default.
- W2435169430 cites W2011568736 @default.
- W2435169430 cites W2012029066 @default.
- W2435169430 cites W2012084077 @default.
- W2435169430 cites W2012194319 @default.
- W2435169430 cites W2012384598 @default.
- W2435169430 cites W2012570517 @default.
- W2435169430 cites W2013832146 @default.
- W2435169430 cites W2014198357 @default.
- W2435169430 cites W2015744228 @default.
- W2435169430 cites W2016807410 @default.
- W2435169430 cites W2017731963 @default.
- W2435169430 cites W2018548683 @default.
- W2435169430 cites W2019889843 @default.
- W2435169430 cites W2020700125 @default.
- W2435169430 cites W2021174550 @default.
- W2435169430 cites W2021391026 @default.
- W2435169430 cites W2021488359 @default.
- W2435169430 cites W2021784258 @default.
- W2435169430 cites W2021885279 @default.
- W2435169430 cites W2023352389 @default.
- W2435169430 cites W2024131627 @default.
- W2435169430 cites W2024824013 @default.
- W2435169430 cites W2025133369 @default.
- W2435169430 cites W2025134886 @default.
- W2435169430 cites W2025695350 @default.
- W2435169430 cites W2026082439 @default.
- W2435169430 cites W2026815148 @default.
- W2435169430 cites W2026833080 @default.
- W2435169430 cites W2026838176 @default.
- W2435169430 cites W2027523662 @default.
- W2435169430 cites W2029224609 @default.
- W2435169430 cites W2029365702 @default.
- W2435169430 cites W2031756458 @default.
- W2435169430 cites W2032227359 @default.
- W2435169430 cites W2032327638 @default.
- W2435169430 cites W2033053243 @default.
- W2435169430 cites W2033486267 @default.
- W2435169430 cites W2034060775 @default.
- W2435169430 cites W2034948888 @default.
- W2435169430 cites W2035159045 @default.
- W2435169430 cites W2035542600 @default.
- W2435169430 cites W2036004307 @default.